Anti-CD89 antibody [EPR4622(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal CD89 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CD89, FCAR, Immunoglobulin alpha Fc receptor, IgA Fc receptor
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD89 antibody [EPR4622(2)] (AB124717)
ab124717 at 1/100 staining CD89 in paraffin embedded Human tonsil tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-CD89 antibody [EPR4622(2)] (AB124717)
CD89 was immunoprecipitated from 0.35 mg U-937 (Human histiocytic lymphoma monocyte) whole cell lysate 10 μg with ab124717 at 1/50 dilution (2μg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : U-937 (Human histiocytic lymphoma monocyte) whole cell lysate 10 μg
Lane 2 : ab124717 IP in U-937 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab124717 in U-937 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CD89 antibody [EPR4622(2)] (ab124717)
Predicted band size: 32 kDa
Observed band size: 70 kDa
false
- WB
Unknown
Western blot - Anti-CD89 antibody [EPR4622(2)] (AB124717)
All lanes:
Western blot - Anti-CD89 antibody [EPR4622(2)] (ab124717) at 1/1000 dilution
Lane 1:
U937 cell lysates at 10 µg
Lane 2:
K562 cell lysates at 10 µg
Lane 3:
Jurkat cell lysates at 10 µg
Lane 4:
HL-60 cell lysates at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 32 kDa
false
Related conjugates and formulations (1)
-
Anti-CD89 antibody [EPR4622(2)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD89 plays an important role in regulating immune surveillance and response. It associates with the gamma chain of the Fc receptor complex which is necessary for its signaling ability. The binding of IgA to CD89 triggers various processes including phagocytosis antibody-dependent cellular cytotoxicity (ADCC) and the release of pro-inflammatory cytokines. These processes are fundamental for host defense against pathogens particularly those entering through mucosal surfaces where IgA is typically abundant.
Pathways
CD89 is part of the immune effector pathway and participates actively in the immunoregulatory signaling cascade. One significant pathway is the IgA-mediated immune response pathway where CD89 cooperates with other Fc receptors and integrins to clear infections. Additionally its interaction with the complement system enhances opsonization and pathogen elimination. Related proteins in these pathways include other Fc receptors like FcγR which share similar signaling mechanisms and immune functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3995 PubMed40301356
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:7784 PubMed39237503
2024
Applications
Unspecified application
Species
Unspecified reactive species
Bio-protocol 12: PubMed35937933
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 10: PubMed35625932
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 20:2752-2764 PubMed32765770
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com